|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/70 | (2006.01) |
| A61K 31/27 | (2006.01) |
| (11) | Number of the document | 2292219 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10179085.5 |
| Date of filing the European patent application | 2006-10-10 | |
| (97) | Date of publication of the European application | 2011-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2013-06-12 |
| (46) | Date of publication of the claims translation | 2013-10-25 |
| (30) | Number | Date | Country code |
| 741511 P | 2005-12-01 | US |
| (72) |
Gargiulo, Paul M., US
Lane, Roger Michael, US
Platt, Beatrix, DE
Theobald, Frank, DE
Wall, Bettina, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
LTS LOHMANN Therapie-Systeme AG, Lohmannstrasse 2, 56626 Andernach, DE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Rivastigmino įvedimo transderminė terapinė sistema |
| Transdermal therapeutic system for the administration of rivastigmine |
| Payment date | Validity (years) | Amount | |
| 2017-10-02 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-07-18 |